Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism.
Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism.
复制标题
DOI:
10.1038/jes.2013.7
复制
发表时间:
2013-09
影响因子:
4.5
通讯作者:
中科院分区:
文献类型:
--
作者:
Tobacco use is the major preventable cause of premature death in the United States. Secondhand smoke (SHS) exposure also contributes to a number of premature deaths as well as other negative health outcomes. An accurate assessment of tobacco smoke exposure is critical to understanding these disease processes. The plasma concentration of cotinine, the primary metabolite of nicotine, is widely accepted as a quantitative measure of tobacco and SHS exposure. However, it is not always feasible to collect plasma. Dried blood spots (DBS), which are collected routinely from newborns and often from young children for lead screening, provide an alternative sampling method. We have developed a quantitative high throughput liquid chromatography tandem mass spectrometry (LC/MS/MS) method for the analysis of cotinine in DBS. The limit of quantitation was 0.3 ng/g (~ 0.2 ng/ml plasma). Cotinine levels in DBS from 83 smokers and 99 nonsmokers exposed to SHS were determined. Plasma cotinine concentrations in these subjects ranged from <0.02 to 443 ng/ml. Cotinine was detected in DBS from 157 subjects, and the correlation between cotinine in plasma and DBS was excellent, 0.992 (p<0.001). We also determined the ratio of trans-3'-hydroxycotinine to cotinine, a measure of nicotine metabolism, in DBS from smokers. This ratio in DBS was well correlated with the ratio in plasma, 0.94 (p<0.001). In a small study we confirmed the feasibility of using extant DBS collected for lead screening to assess SHS exposure in children.
登录
查看更多内容
DOI:
10.1158/1055-9965.epi-10-0674
发表时间:
2011-02
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Strasser AA;Benowitz NL;Pinto AG;Tang KZ;Hecht SS;Carmella SG;Tyndale RF;Lerman CE
通讯作者:
Lerman CE
影响因子:
2.6
作者:
Bloom J;Hinrichs AL;Wang JC;von Weymarn LB;Kharasch ED;Bierut LJ;Goate A;Murphy SE
通讯作者:
Murphy SE
DOI:
10.1001/archpediatrics.2012.170
发表时间:
2012-09-01
影响因子:
--
作者:
Dempsey, Delia A.;Meyers, Matthew J.;Oh, Sam S.;Nguyen, Elizabeth A.;Fuentes-Afflick, Elena;Wu, Alan H. B.;Jacob, Peyton, III;Benowitz, Neal L.
通讯作者:
Benowitz, Neal L.
影响因子:
11.4
作者:
Spliethoff, Henry M.;Tao, Lin;Eadon, George A.
通讯作者:
Eadon, George A.
影响因子:
4.2
作者:
Mei, JV;Alexander, JR;Hannon, WH
通讯作者:
Hannon, WH